The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Spring Bank (SBPH) presented data for their Phase 2 ACHIEVE trial at EASL conference today, including their 200mg cohort. Data was in line with expectations and confirms … Continue Reading
Read nowInsights - This morning Aldeyra released topline data for their Phase 3 candidate reproxalap in allergic conjunctivitis. The company showed statistical significance in both primary and secondary endpoints Primary … Continue Reading
Read nowInsights - Spring Bank provided a business update earlier this week to discuss 2019 development plant for their immune-modulator inarigivir in treating Hepatitis B. Although the company also discussed … Continue Reading
PremiumInsights - Fennec announced some bad news this morning. Their NDA submission for Pedmark has been pushed back by 9-12 months to “late 2019 to early 2020”. The NDA … Continue Reading
Read nowInsights - This morning, Aldeyra hosted their R&D day, where they discussed their pipeline and upcoming plans. Although no AC data was reported, the company did give color … Continue Reading
Read nowInsights - It seems the market is starting to realize Bellus’ potential as the company touched a 52 week high today on the Canadian listing when it … Continue Reading
Read nowInsights - Today Fennec (FENC) announced a $12.5 million senior loan with the Life Sciences Group at Bridge Bank. The loan will have a maturity date of October 1, … Continue Reading
Read now
